Bayer Cropscience Ag

Bayer Animal Health Gmbh

Bayer Intellectual Property Gmbh

Bayal Animal Health Gmbh

Maike Hink

Hans-Georg Schwarz

Joerg Nico Greul

Axel Trautwein

Martin Adamczewski

Mark Wilhelm Drewes

Arnd Voerste

Kerstin Ilg

Roland Andree

Daniela Portz

Ulrich Goergens

Angela Becker

Johannes-Rudolf Jansen

Eike Kevin Heilmann

Peter Luemmen

Isabelle Adelt

Ulrich Görgens

Claudia Welz

Walter Hübsch

Adeline Köhler

Johannes Köbberling

Thomas Simon Ilg

Kirsten Börngen

Wei Zhuang

Daniel Kulke

Claudia Böhm

Nils Griebenow

Niels Lindner

Lothar Willms

Pierre-Yves Coqueron

Walter Hubsch

Achim Harder

Bernd Alig

Iring Heisler

Ulrich Ebbinghaus-Kintscher

Peter Lümmen

Klaus Raming

Peter Lummen

Jorg Greul

Nils Griebnow

Dirk Nennstiel

Jörg Greul

Johannes Kobberling

Claudia Bohm

Adeline Kohler

Kirsten Borngen

Ulrich Gorgens

Mark Drewes

Thomas Ilg

Zhuang Wei

Adeline KÖHLER

The present invention covers new quinoline compounds of general formula (I), in which A, R, R, R, R, R, R, and Q are as defined herein, methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions and combinations comprising said compounds and the use of said compounds for manufacturing pharmaceutical compositions for the treatment, control and/or prevention of diseases, in particular of helminth infections, as a sole agent or in combination with other active ingredients. 

Quinoline derivatives

The present application relates to the use of heterocyclic compounds for controlling animal pests including arthropods, insects and nematodes, to novel heterocyclic compounds, to processes for their preparation and to intermediates for preparing the heterocyclic compounds.

Heterocyclic compounds as pesticides

The present invention covers new quinoline compounds of general formula (I): in which A, R, R, R, R, R, R, and Q are as defined herein, methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions and combinations comprising said compounds and the use of said compounds for manufacturing pharmaceutical compositions for the treatment, control and/or prevention of diseases, in particular of helminth infections, as a sole agent or in combination with other active ingredients.

Anthelmintic quinoline-3-carboxamide derivatives

The present invention covers new quinoline compounds of general formula (I) in which A, R, R, R, R, R, R, and Q are as defined herein, methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions and combinations comprising said compounds and the use of said compounds for manufacturing pharmaceutical compositions for the treatment, control and/or prevention of diseases, in particular of helminth infections, as a sole agent or in combination with other active ingredients. 

The present invention covers Pyrazolopyrimidine compounds of general formula (I), in which n, o, X, Y, R, Q, R, R, Rand Rare as defined herein, methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions and combinations comprising said compounds and the use of said compounds for manufacturing pharmaceutical compositions for the treatment, control and/or prevention of diseases, in particular of helminth infections, as a sole agent or in combination with other active ingredients. 

Pyrazolopyrimidine derivatives

The present application relates to known and novel aryl- and hetarylcarboxamides of the formula (I) and to their use as medicaments for controlling endoparasites in animals or humans, and also to parasiticidal compositions, in particular endoparasites, comprising aryl- and hetarylcyclylcarboxamides.

Use of aryl and hetaryl carboxamides as endoparasiticides

Growing community of inventors

Markgroeningen, Germany

Maike Hink